Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXB3 | hg38_v1_chr17_-_48590231_48590258 | 0.52 | 2.0e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_88885397 Show fit | 6.05 |
ENST00000390243.2
|
immunoglobulin kappa variable 4-1 |
|
chr14_-_106038355 Show fit | 4.54 |
ENST00000390597.3
|
immunoglobulin heavy variable 2-5 |
|
chr22_+_22811737 Show fit | 4.44 |
ENST00000390315.3
|
immunoglobulin lambda variable 3-10 |
|
chr2_-_88861563 Show fit | 4.32 |
ENST00000624935.3
ENST00000390241.3 |
novel transcript immunoglobulin kappa joining 2 |
|
chr22_+_22720615 Show fit | 4.19 |
ENST00000390309.2
|
immunoglobulin lambda variable 3-19 |
|
chr2_-_89177160 Show fit | 4.07 |
ENST00000484817.1
|
immunoglobulin kappa variable 2-24 |
|
chr4_-_25863537 Show fit | 4.00 |
ENST00000502949.5
ENST00000264868.9 ENST00000513691.1 ENST00000514872.1 |
SEL1L family member 3 |
|
chr14_-_106470788 Show fit | 3.65 |
ENST00000434710.1
|
immunoglobulin heavy variable 3-43 |
|
chr2_+_90038848 Show fit | 3.10 |
ENST00000390270.2
|
immunoglobulin kappa variable 3D-20 |
|
chr22_+_22375984 Show fit | 2.97 |
ENST00000390296.2
|
immunoglobulin lambda variable 5-45 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 21.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 13.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.7 | 5.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
1.3 | 4.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.0 | 3.9 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 3.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 3.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 2.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 2.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 2.0 | GO:0070206 | protein trimerization(GO:0070206) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 3.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 3.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 2.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 2.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 2.2 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 2.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.4 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.1 | 1.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 32.9 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 5.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 4.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 3.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.1 | 3.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 2.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 2.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 3.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 4.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 3.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |